We hypothesise that BTG integration within structured telehealth support will enhance glycemic control, reduce diabetes-related emotional distress, and improve the efficiency of remote insulin titration processes, ultimately optimizing patient care delivery and healthcare resource utilisation. The gene discussed is INS; the disease is diabetes mellitus.